# Clinical-Virology Core

> **NIH NIH U54** · STANFORD UNIVERSITY · 2022 · $486,601

## Abstract

CLINICAL AND VIROLOGY CORE: SUMMARY
The Clinical and Virology Core (CVC) of the U54 will continue and expand recruitment of clinical cohorts of
COVID-19 patients with increased proportions of populations at risk for severe disease and medically
underserved. The CVC will provide state-of-the-art biospecimen support for Projects 1- 3 and clinical and assay
data to the Administrative/Data Analysis Core. The CVC will also oversee personnel and procedures to
implement and manage the clinical cohorts, and serve as the hub from which all Projects will obtain high-quality
deidentified clinical and virologic data, and optimally preserved patient specimens from each patient. In addition,
the CVC will be a focus of new immunological and virology assay development, with the goal (and established
track record) of rapid translation to implementation in CLIA-regulated Clinical Laboratories.

## Key facts

- **NIH application ID:** 10688363
- **Project number:** 4U54CA260517-02
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** Kari C. Nadeau
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $486,601
- **Award type:** 4N
- **Project period:** 2020-09-23 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10688363

## Citation

> US National Institutes of Health, RePORTER application 10688363, Clinical-Virology Core (4U54CA260517-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10688363. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*